These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8386233)

  • 1. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of gallium arsenide-induced suppression of the antibody response by a mixed disulfide metabolite of meso-2,3-dimercaptosuccinic acid.
    Burns LA; Butterworth LF; Munson AE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):695-700. PubMed ID: 8382280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
    Burns LA; Sikorski EE; Saady JJ; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response.
    Sikorski EE; Burns LA; Stern ML; Luster MI; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):129-42. PubMed ID: 1871769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):178-86. PubMed ID: 8097242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
    Burns LA; McCay JA; Brown R; Munson AE
    J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium arsenide-induced increase in serum corticosterone is not responsible for suppression of the IgM antibody response.
    Burns LA; Spriggs TL; Fuchs BA; Munson AE
    J Pharmacol Exp Ther; 1994 Feb; 268(2):740-6. PubMed ID: 7509391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of splenic accessory cell function in mice exposed to gallium arsenide.
    Sikorski EE; Burns LA; McCoy KL; Stern M; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):143-56. PubMed ID: 1714636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation.
    Lewis TA; Munson AE; McCoy KL
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1244-51. PubMed ID: 8819508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
    Flora SJ; Kannan GM; Pant BP; Jaiswal DK
    Arch Toxicol; 2002 Jun; 76(5-6):269-76. PubMed ID: 12107644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct exposure to gallium arsenide upregulates costimulatory activity of murine macrophages.
    Caffrey-Nolan RE; McCoy KL
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):330-9. PubMed ID: 9707509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of meso 2,3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats.
    Flora SJ; Bhatt K; Dwivedi N; Pachauri V; Kushwah PK
    Clin Exp Pharmacol Physiol; 2011 Jul; 38(7):423-9. PubMed ID: 21501211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by alpha-naphthoflavone.
    Kawabata TT; White KL
    Cancer Res; 1987 May; 47(9):2317-22. PubMed ID: 3567925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro solubility and in vivo toxicity of gallium arsenide.
    Webb DR; Sipes IG; Carter DE
    Toxicol Appl Pharmacol; 1984 Oct; 76(1):96-104. PubMed ID: 6484996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium arsenide exposure impairs processing of particulate antigen by macrophages: modification of the antigen reverses the functional defect.
    Hartmann CB; McCoy KL
    Life Sci; 2004 Jun; 75(4):485-98. PubMed ID: 15147834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice.
    Sikorski EE; McCay JA; White KL; Bradley SG; Munson AE
    Fundam Appl Toxicol; 1989 Nov; 13(4):843-58. PubMed ID: 2695379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso-2,3-dimercaptosuccinic acid and 2,3-dimercaptopropane 1-sulfonate administration in rats.
    Flora SJ; Kumar P
    Environ Toxicol Pharmacol; 1996 Dec; 2(4):315-20. PubMed ID: 21781736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation.
    Hartmann CB; McCoy KL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):365-72. PubMed ID: 8975760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallium arsenide exposure impairs splenic B cell accessory function.
    Gondre-Lewis TA; Hartmann CB; Caffrey RE; McCoy KL
    Int Immunopharmacol; 2003 Mar; 3(3):403-15. PubMed ID: 12639818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.